Rocket


News + Filings
Transactions
Holdings





InvaGen Pharmaceuticals, Inc.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/11/2022AVENUE THERAPEUTICS, INC.ATXISaleCommon Stock, par value $0.0001 per share388.9k$7.71$3M 10/11/2022

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy